Clinical trial

The Effect of Intravenous Infusion of Tramadol-ondansetron on Recovery After Caesarean Section. A Prospective, Observational and Non-inferiority Study Against Epidural Analgesia.

Name
TRON
Description
It will be a prospective observational cohort study. The investigators will compare post-cesarean section recovery in patients receiving intravenous infusion of tramadol-ondansetron versus epidural catheter with infusion of local anesthetics.
Trial arms
Trial start
2023-05-23
Estimated PCD
2024-02-28
Trial end
2024-02-28
Status
Recruiting
Treatment
Tramadol-ondansetron continuous infusion
Analgesia strategy determined by routine use according to protocols, without investigator intervention.
Arms:
TRON (Tramadol-Ondansetron)
Ropivacaine via epidural catheter
Analgesia strategy determined by routine use according to protocols, without investigator intervention.
Arms:
AL-EPI (Local anesthetics via epidural)
Size
312
Primary endpoint
Post-surgical recovery
Day 1
Eligibility criteria
Inclusion Criteria: * Woman over 18 years old undergoing caesarean section * She agrees to participate voluntarily. * She is already receiving any of the analgesic strategies studied. Exclusion Criteria: * Receiving an analgesic medication other than the one mentioned as "routine multimodal analgesia" (either as regular medication or for acute post-surgical pain) * Medical history that determines the baseline data of the scales and data that we collect ( pain or previous disabilities; addiction to drugs, alcohol or drugs; another disease that worsens the quality of life) * Medical history that conditions the pharmacological effect (allergy, intolerance or atypical reaction to any of the drugs involved in its treatment or possible cross-reactions ) * Contraindication for neuraxial techniques (patient refusal, difficulty in understanding or communication, localized infection, increased intracranial pressure, or other medical criteria) * Two or more previous caesarean sections * Difficulty in understanding or communication
Protocol
{'studyType': 'OBSERVATIONAL', 'patientRegistry': False, 'designInfo': {'observationalModel': 'COHORT', 'timePerspective': 'PROSPECTIVE'}, 'enrollmentInfo': {'count': 312, 'type': 'ESTIMATED'}}
Updated at
2023-05-30

1 organization

2 products

9 indications

Indication
c-section
Indication
Tramadol
Indication
Ondansetron
Indication
QoR-15
Indication
ObsQor-10